Abstract
A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser, or laser toning, has yielded favorable outcomes in various benign pigmented disorders. However, the exact mechanism of action of laser toning has not been fully elucidated. We sought to determine the inhibitory effect of laser toning on melanogenesis and to assess how laser passes influence the outcomes. To produce perceptible pigmentation, nine HRM-2 melanin-possessing hairless mice were treated with ultraviolet (UV) B radiation on the dorsal skin. This was followed by zero, two, four, or six passes of laser toning twice in 2 weeks on each designated quadrant. The spectrophotometric values and pigmentation-related protein expressions were measured. Pigment changes were found in the mice skin using the Fontana-Masson stain for histopathological analysis. Four- and six-pass laser toning significantly improved the lightness compared to that in the unirradiated control (p < 0.002). The Fontana-Masson stain showed that melanin was considerably decreased in laser-irradiated skin. As the number of laser passes increased, the expression of tyrosinase decreased (p < 0.008). The following parameters also decreased in proportion to the number of laser passes: MITF, TRP-1, TRP-2, p-ERK, and p-Akt. In contrast, TGF-β increased in proportion to the number of laser passes. However, the changes in these six proteins were not statistically significant. Our study demonstrates that laser toning improves skin pigmentation with increased number of passes in a dose-dependent manner. This effect is mediated by tyrosinase inhibition.
Similar content being viewed by others
References
Halder RM, Nootheti PK (2003) Ethnic skin disorders overview. J Am Acad Dermatol 48(6 Suppl):S143–S148. doi:10.1067/mjd.2003.274
Ho SG, Chan HH (2009) The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol 10(3):153–168. doi:10.2165/00128071-200910030-00002
Grimes P, Nordlund JJ, Pandya AG, Taylor S, Rendon M, Ortonne JP (2006) Increasing our understanding of pigmentary disorders. J Am Acad Dermatol 54(5 Suppl 2):S255–S261. doi:10.1016/j.jaad.2005.12.042
Korner A, Pawelek J (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217(4565):1163–1165
Mastore M, Kohler L, Nappi AJ (2005) Production and utilization of hydrogen peroxide associated with melanogenesis and tyrosinase-mediated oxidations of DOPA and dopamine. FEBS J 272(10):2407–2415. doi:10.1111/j.1742-4658.2005.04661.x
Shibahara S, Takeda K, Yasumoto K, Udono T, Watanabe K, Saito H, Takahashi K (2001) Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc 6(1):99–104
Vachtenheim J, Borovansky J (2010) “Transcription physiology” of pigment formation in melanocytes: central role of MITF. Exp Dermatol 19(7):617–627. doi:10.1111/j.1600-0625.2009.01053.x
Busca R, Ballotti R (2000) Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13(2):60–69
Kim D-S, Park S-H, Park K-C (2004) Transforming growth factor-β1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol 36(8):1482–1491
Oka M, Nagai H, Ando H, Fukunaga M, Matsumura M, Araki K, Ogawa W, Miki T, Sakaue M, Tsukamoto K (2000) Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol 115(4):699–703
Jang JY, Lee JH, Kang BW, Chung KT, Choi YH, Choi BT (2009) Dichloromethane fraction of Cimicifuga heracleifolia decreases the level of melanin synthesis by activating the ERK or AKT signaling pathway in B16F10 cells. Exp Dermatol 18(3):232–237. doi:10.1111/j.1600-0625.2008.00794.x
Lee HJ, Lee WJ, Chang SE, Lee GY (2015) Hesperidin, a popular antioxidant inhibits melanogenesis via Erk1/2 mediated MITF degradation. Int J Mol Sci 16(8):18384–18395. doi:10.3390/ijms160818384
DeHoratius DM, Dover JS (2007) Nonablative tissue remodeling and photorejuvenation. Clin Dermatol 25(5):474–479. doi:10.1016/j.clindermatol.2007.05.006
Alam M, Dover JS (2003) Nonablative laser and light therapy: an approach to patient and device selection. Skin Therapy Lett 8(4):4–7
Choi CW, Kim HJ, Lee HJ, Kim YH, Kim WS (2014) Treatment of nevus of Ota using low fluence Q-switched Nd:YAG laser. Int J Dermatol 53(7):861–865. doi:10.1111/ijd.12085
Kim JH, Kim H, Park HC, Kim IH (2010) Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation. J Invest Dermatol 130(9):2333–2335. doi:10.1038/jid.2010.129
Mun JY, Jeong SY, Kim JH, Han SS, Kim IH (2011) A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc 60(1):11–18. doi:10.1093/jmicro/dfq068
Kim JE, Chang SE, Yeo UC, Haw S, Kim IH (2013) Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium:yttrium-aluminium-garnet laser. Clin Exp Dermatol 38(2):167–171. doi:10.1111/j.1365-2230.2012.04473.x
Omi T, Yamashita R, Kawana S, Sato S, Naito Z (2012) Low fluence Q-switched Nd: YAG laser toning and Q-switched ruby laser in the treatment of melasma: a comparative split-face ultrastructural study. Laser therapy 21(1):15
Kim HR, Ha JM, Park MS, Lee Y, Seo YJ, Kim CD, Lee JH, Im M (2015) A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of cafe-au-lait macules. J Am Acad Dermatol 73(3):477–483. doi:10.1016/j.jaad.2015.06.002
Alam M, Hsu TS, Dover JS, Wrone DA, Arndt KA (2003) Nonablative laser and light treatments: histology and tissue effects—a review. Lasers Surg Med 33(1):30–39. doi:10.1002/lsm.10195
Yun CY, You ST, Kim JH, Chung JH, Han SB, Shin EY, Kim EG (2015) p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and beta-catenin/MITF pathways. J Invest Dermatol 135(5):1385–1394. doi:10.1038/jid.2014.548
Cho SB, Kim JS, Kim MJ (2009) Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol 34(8):e847–e850. doi:10.1111/j.1365-2230.2009.03599.x
Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS (1989) Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 93(1):28–32. doi:10.1111/1523-1747.ep12277339
Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I, Hercogova J, Lotti T (2001) Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Dermatol Venereol 15(6):559–565
Landau JM, Vergilis-Kalner I, Goldberg LH, Geronemus RG, Friedman PM (2011) Treatment of nevus of Ota in Fitzpatrick skin type VI with the 1064-nm QS Nd:YAG laser. Lasers Surg Med 43(2):65–67. doi:10.1002/lsm.21011
Seo HM, Choi CW, Kim WS (2015) Beneficial effects of early treatment of nevus of Ota with low-fluence 1064-nm Q-switched Nd:YAG laser. Dermatol Surg 41(1):142–148. doi:10.1097/dss.0000000000000212
Bennett NT, Schultz GS (1993) Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165(6):728–737
Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9(4):447–453. doi:10.1016/j.coph.2009.04.008
Safavi SM, Kazemi B, Esmaeili M, Fallah A, Modarresi A, Mir M (2008) Effects of low-level He-Ne laser irradiation on the gene expression of IL-1beta, TNF-alpha, IFN-gamma, TGF-beta, bFGF, and PDGF in rat’s gingiva. Lasers Med Sci 23(3):331–335. doi:10.1007/s10103-007-0491-5
Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, Kolbe L, Hearing VJ (2010) Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB. J Invest Dermatol 130(6):1685–1696. doi:10.1038/jid.2010.5
Oh CT, Lee D, Koo K, Lee J, Yoon HS, Choi YM, Kwon TR, Kim BJ (2014) Superoxide dismutase 1 inhibits alpha-melanocyte stimulating hormone and ultraviolet B-induced melanogenesis in murine skin. Ann Dermatol 26(6):681–687. doi:10.5021/ad.2014.26.6.681
Acknowledgements
We would like to thank the following individuals for their help, without whose support this study would have never been completed: Yeon Hwa Yoo, M.D., whose task of drawing a figure was essential to this thesis; Han-Saem Kim, M.D., Ju-Yeon Choi, M.D., and Jae Yun Lim, M.D. for generously contributing their valuable time and effort to care for the experimental mice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was done without financial support.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving animals and human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
This article does not contain any studies with participants that should have informed consent.
Additional information
Jae-Hui Nam and Joon Hong Min contributed equally to this work.
Electronic supplementary material
Supplementary Fig. 1
Effects of laser toning on UVA- or UVB-induced pigmentation in human abdominal skin (n = 1). a The photographs indicate pigmentary changes following laser toning (left, before laser treatment; right, after completion of laser treatment). b Western blot results demonstrate altered expressions of MITF and tyrosinase in a dose-dependent manner in UVA-induced pigmentation. In contrast, there are ambiguous results with UVB-induced pigmentation (GIF 422 kb)
ESM 1
(GIF 293 kb)
Supplementary Table 1
Ultraviolet (UV) A and B irradiation and laser schedules in a human (n = 1) (DOCX 24 kb)
Rights and permissions
About this article
Cite this article
Nam, JH., Min, J.H., Kim, WK. et al. Melanogenesis inhibition in mice using a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser: a pilot study. Lasers Med Sci 32, 1063–1069 (2017). https://doi.org/10.1007/s10103-017-2208-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2208-8